Sipra Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.1/10
Best for: compounded GLP-1 shoppers willing to prepay three months or more for one price at every dose
Price is where Sipra scores best in our breakdown.
Semaglutide
Tirzepatide
What the monthly price covers
Medication
Included
Provider visits
Included
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Sipra is a telehealth platform that prescribes compounded semaglutide and tirzepatide as weekly injections, lower-dose microdose injections or dissolving tablets, with physicians from MDI Medical Group. There is no month-to-month option: the shortest plan is three months, paid up front once a physician approves, at $189/mo for semaglutide and $249/mo for tirzepatide. Longer plans cost less per month, the price does not rise with your dose, and shipping is free.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Sipra
Editorial score · methodology
Collective
Best for: the lowest flat medication price if you can absorb an annual membership fee
Editorial score · methodology
Editorial score · methodology
Sipra at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $149/mo
- Pricing model
- Flat — dose increases don't raise the monthly price
- What's included
- Medication · Consult · Shipping
- FDA status
- No FDA warning letter on record
How we scored Sipra
Each dimension is scored algorithmically from Sipra’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
8.0/10At $149/mo, Sipra runs about 12% below the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.
Effectiveness25%
7.7/10Sipra offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
6.9/10Online intake and platform experience — consult included in the price; 8 platform features disclosed.
Trust & Safety15%
6.8/10Core details confirmed by our editors; no FDA warning letters on file.
Accessibility10%
5.6/10Sipra's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.4/10Sipra provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Sipra review
Last checked October 2026- Confirmed current pricing across 6 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $149–$269/mo across 6 dose/plan tiers — checked October 2026
- FDA warning-letter register
- No letter on file for this provider
What to expect when you sign up with Sipra
We walked Sipra’s public signup flow in October 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Open the pricing page: every weight-loss treatment shows its 3-, 6- and 12-month monthly rate and plan total, with no quiz
- 2On the weight-loss page, tap how much weight you want to lose to open the online visit
- 3Section 1 of 3 asks your state, then your height and weight, then a goal weight on a slider
- 4The next screen asks for your email address before any health question (walk stopped here)
- 5The site says a physician then reviews the intake, and the plan total is charged once, only if treatment is approved
- Every price is public, but the weight-loss page headlines "From $149/mo" and only a footnote says that is the 12-month rate
- No one-month plan is offered for weight loss, although the terms and refund policy still describe a 1-month plan length
- Multi-month plans are one up-front charge after approval; medication then ships one quarter at a time
- The state menu lists all 50 states and Washington, D.C., but the eligible-state page the terms point to returns a not-found error
- The terms name MDI Medical Group as the practice, but a consent paragraph in the same terms names a different set of medical groups
- No phone number is published; support runs through email, an on-site chat assistant and portal messaging
- We did not take the medication; nothing here describes a patient outcome
GLP-1 medications Sipra offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Shortest plan offered. 6-month plan $169/mo ($1,014 up front); 12-month plan $149/mo ($1,788 up front).
Shortest plan offered. 6-month plan $219/mo ($1,314 up front); 12-month plan $199/mo ($2,388 up front).
Low-dose program. 6-month plan $129/mo ($774 up front); 12-month plan $119/mo ($1,428 up front).
Low-dose program. 6-month plan $179/mo ($1,074 up front); 12-month plan $159/mo ($1,908 up front).
Daily tablet with B6. 6-month plan $219/mo ($1,314 up front); 12-month plan $199/mo ($2,388 up front).
Daily tablet. 6-month plan $249/mo ($1,494 up front); 12-month plan $239/mo ($2,868 up front).
Ready to get started?
Plans and promotions change often — check Sipra's current pricing and active discounts before you decide.
What we like
- Every plan length, monthly rate and plan total is published on the pricing page before you answer a single question
- One price at every dose: the rate is set by plan length and does not rise as your physician steps the dose up
- Medication, physician review, dose changes, messaging and expedited shipping are in the plan price, with no membership fee
- Your card is charged only after a physician approves treatment; if treatment is declined, you owe nothing
- Six GLP-1 formats: semaglutide or tirzepatide as weekly injections, lower-dose microdose injections or dissolving tablets
- Names its prescribing group (MDI Medical Group) and its pharmacy partners in its terms
- Cancel online in your account, with no phone call or retention script
- HSA and FSA eligible; metformin, low-dose naltrexone, menopause hormone therapy and a lab panel are on the same account
Watch-outs
- No month-to-month option: the shortest plan is three months, charged as one up-front payment (for example, $567 for semaglutide)
- The headline "from $149/mo" is the 12-month rate; standard semaglutide costs $189/mo on the shortest plan
- Three-month plans are not refundable once a physician approves, even if nothing has shipped yet
- Leaving a 6- or 12-month plan early re-prices the months you keep at the higher shorter-plan rate before the rest is refunded
- Plans renew automatically at the rate posted at renewal; cancel at least 13 days before the period ends to stop the next order
- No phone support is published; help is by email, on-site chat and portal messaging
- A new brand: its current terms and refund policy took effect in October 2026, so there is little track record to judge
- Compounded semaglutide and tirzepatide are not FDA-approved
Is Sipra worth it?
Sipra's whole pitch comes down to this: compounded GLP-1 shoppers willing to prepay three months or more for one price at every dose. It runs $149/month, the same price at every dose, — toward the affordable end of the category, so cost isn't the reason to look elsewhere. Its standout is a needle-free oral option, which very few providers offer.
Sipra offers a microdosing option. It also charges the same price at every dose and charges no membership fee.
How much Sipra actually costs
Compounded semaglutide runs $189/month, compounded tirzepatide runs $249/month, compounded semaglutide runs $149/month, compounded tirzepatide runs $199/month, compounded semaglutide runs $249/month, and compounded tirzepatide runs $269/month.
That puts Sipra below the roughly $169 median ongoing price across the GLP-1 providers we track — a real cost advantage.
altRX (about $149/month) is one of the closest alternatives to weigh Sipra against.
Medications: what Sipra prescribes
Sipra prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two most-studied weight-loss molecules on the market today. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.
Sipra's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.
Who Sipra is best for — and who should skip it
A good fit if you…
- are focused on the lowest ongoing monthly cost — $149/month is below the roughly $169 median we track across the category.
- are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.
Look elsewhere if you…
- specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
- need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.
Trust, safety, and medical oversight
We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.
Bottom line
Sipra earns its place on the shortlist mainly on price: at $149/month it's one of the more affordable ways to stay on a GLP-1, without obvious corners cut on access or oversight.
The Bottom Line
Price is where Sipra scores best in our breakdown.
Ready to start with Sipra?
Starting at $149/month. See current pricing and start your free consultation.
Sipra might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Sipra review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Sipra's current pricing
Plans start at $149/month. Start your free consultation to check eligibility and today's price.